Last reviewed · How we verify
Serum and plasma samples — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Serum and plasma samples (Serum and plasma samples) — Hospices Civils de Lyon.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Serum and plasma samples TARGET | Serum and plasma samples | Hospices Civils de Lyon | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Serum and plasma samples CI watch — RSS
- Serum and plasma samples CI watch — Atom
- Serum and plasma samples CI watch — JSON
- Serum and plasma samples alone — RSS
Cite this brief
Drug Landscape (2026). Serum and plasma samples — Competitive Intelligence Brief. https://druglandscape.com/ci/serum-and-plasma-samples. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing